API Manufacturing
Route design, impurity control, and kilo-scale production managed through an audited CMO network—covering mineral, organic, and high-potency chemistries
Route design, impurity control, and kilo-scale production managed through an audited CMO network—covering mineral, organic, and high-potency chemistries
Fluid-bed, melt, and extrusion processes deliver uniform pellets and granules that shorten downstream dosage timelines
Tablets, capsules, liquids, and parenterals—developed under QbD and packaged for rapid tech transfer to partner plants
Controlled-release and targeted platforms that fit bioavailability, extend patient life, and enhance patient adherence
Recombinant proteins, monoclonal antibodies, and vaccine antigens engineered in certified partner bioreactors

Concept-to-commission facility design, HVAC and utility schematics, and turnkey validation packages for GMP readiness.

Tech-transfer, regulatory dossier authoring, and quality audits that move products smoothly across borders.

Flexible co-development and co-manufacturing models that share science, speed, and commercial upside.
Opioid-sparing combinations, sublingual innovations, and sustained-release matrices developed for consistent, once-daily relief.
Next-generation oral therapies—including GLP-1 agonist and SGLT-2 inhibitor platforms—formulated for superior adherence.
Targeted small-molecule and supportive-care injectables produced under stringent potency and containment protocols.
Multiple-sclerosis, transplant, and autoimmune candidates leveraging advanced chemo- and biotechnologies.
Evidence-based wellness formulations—minerals, adaptogens, cognitive and metabolic blends—manufactured to HACCP standards